Actively Recruiting
A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors
Led by Guangzhou Virotech Pharmaceutical Co., Ltd. · Updated on 2025-03-13
12
Participants Needed
3
Research Sites
127 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A Phase I Study of the Safety and Tolerability of M1-c6v1 Administered Via Intravenously for Treatment of Patients With Locally Advanced or Metastatic Solid Tumors
CONDITIONS
Official Title
A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of locally advanced or metastatic solid tumors intolerant or refractory to standard therapy
- Voluntary agreement to participate and signed informed consent before screening
- Male or female aged 18 years or older at screening
- At least one measurable tumor lesion
- ECOG performance status of 0 or 1 within 1 week before first dose
- Estimated survival time of at least 12 weeks
You will not qualify if you...
- History of immunodeficiency, leukemia, lymphoma, AIDS, or HIV infection or immunosuppressive therapy
- Received any anti-tumor treatment within 4 weeks before first study drug administration
- Taken systemic glucocorticoids over 10 mg/day or similar immunosuppressive drugs within 14 days before first dose
- Received immunomodulatory drugs such as thymosin, IL-2, or interferon within 14 days before first dose
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
National Cancer Center Hospital East
Kashiwa-shi, Chiba, Japan
Actively Recruiting
2
National Hospital Organization Shikoku Cancer Center
Matsuyama, Ehime, Japan
Actively Recruiting
3
St. Marianna University Hospital
Kawasaki-shi, Kanagawa, Japan
Actively Recruiting
Research Team
G
Guangzhou Virotech Pharmaceutical Co., Ltd.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here